Home/Filings/4/0001209191-22-036085
4//SEC Filing

Hanley Jr. Michael Conick 4

Accession 0001209191-22-036085

CIK 0001636282other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 6:24 PM ET

Size

4.8 KB

Accession

0001209191-22-036085

Insider Transaction Report

Form 4
Period: 2022-06-08
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-06-08$0.71/sh+28,200$20,02236,200 total
Footnotes (1)
  • [F1]Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.

Issuer

Aeglea BioTherapeutics, Inc.

CIK 0001636282

Entity typeother

Related Parties

1
  • filerCIK 0001791413

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 6:24 PM ET
Size
4.8 KB